PROCEPT BioRobotics Corp. (PRCT)
17.16
+0.14
(+0.82%)
USD |
NASDAQ |
Oct 02, 16:00
17.17
+0.01
(+0.06%)
After-Hours: 20:00
PROCEPT BioRobotics Gross Profit Margin (Quarterly) : 66.01% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.01% |
| March 31, 2026 | 64.89% |
| December 31, 2025 | 60.63% |
| September 30, 2025 | 62.87% |
| June 30, 2025 | 63.35% |
| March 31, 2025 | 63.85% |
| December 31, 2024 | 64.00% |
| September 30, 2024 | 60.96% |
| June 30, 2024 | 56.63% |
| March 31, 2024 | 53.55% |
| December 31, 2023 | 45.75% |
| September 30, 2023 | 50.77% |
| Date | Value |
|---|---|
| June 30, 2023 | 54.27% |
| March 31, 2023 | 45.91% |
| December 31, 2022 | 44.90% |
| September 30, 2022 | 43.20% |
| June 30, 2022 | 47.12% |
| March 31, 2022 | 54.18% |
| December 31, 2021 | 44.55% |
| September 30, 2021 | 48.92% |
| June 30, 2021 | 33.18% |
| March 31, 2021 | 49.04% |
| December 31, 2020 | 14.59% |
| September 30, 2020 | -1.47% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Insulet Corp. | 72.56% |
| Globus Medical, Inc. | 65.92% |
| Abbott Laboratories | 52.64% |
| Stryker Corp. | 66.14% |
| AngioDynamics, Inc. | 50.87% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -30.16% |
| Return on Assets | -21.96% |
| Return on Invested Capital | -24.81% |
| Profit Margin (Quarterly) | -28.42% |
| Operating Margin (Quarterly) | -28.98% |
| Return on Net Operating Assets | -51.60% |